It is also possible that MYC may play a role in the differential activity of the RUNX1 superenhancer in BL cells compared to LCLs, since BL cells express high levels of MYC as a result of the MYC-IG translocation. This evidence concerns the gene RUNX1 and Burkitt lymphoma.